Copyright Reports & Markets. All rights reserved.

Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Aspirin
      • 1.4.3 Ibuprofen
      • 1.4.4 Naproxen
      • 1.4.5 Celecoxib
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2014-2025)
      • 1.5.2 Drug Store
      • 1.5.3 Hospital Pharmacies
      • 1.5.4 Online
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size
    • 2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Regions
      • 2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Regions (2014-2025)
      • 2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Manufacturers
      • 3.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)
    • 3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players Head office and Area Served
    • 3.3 Key Players Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product/Solution/Service
    • 3.4 Date of Enter into Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2014-2019)
    • 4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 5.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in United States
    • 5.3 United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 5.4 United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    6 Europe

    • 6.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 6.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Europe
    • 6.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 6.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    7 China

    • 7.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 7.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in China
    • 7.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 7.4 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    8 Japan

    • 8.1 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 8.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Japan
    • 8.3 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 8.4 Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 9.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Southeast Asia
    • 9.3 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 9.4 Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    10 India

    • 10.1 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 10.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in India
    • 10.3 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 10.4 India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2014-2019)
    • 11.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Key Players in Central & South America
    • 11.3 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
    • 11.4 Central & South America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

    12 International Players Profiles

    • 12.1 Roche (including Genentech)
      • 12.1.1 Roche (including Genentech) Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.1.4 Roche (including Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.1.5 Roche (including Genentech) Recent Development
    • 12.2 Amgen
      • 12.2.1 Amgen Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.2.5 Amgen Recent Development
    • 12.3 B-MS
      • 12.3.1 B-MS Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.3.5 B-MS Recent Development
    • 12.4 Merck
      • 12.4.1 Merck Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.4.5 Merck Recent Development
    • 12.5 Pfizer
      • 12.5.1 Pfizer Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.5.5 Pfizer Recent Development
    • 12.6 Novartis
      • 12.6.1 Novartis Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.6.5 Novartis Recent Development
    • 12.7 Eli Lilly and Company
      • 12.7.1 Eli Lilly and Company Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.7.5 Eli Lilly and Company Recent Development
    • 12.8 Johnson & Johnson
      • 12.8.1 Johnson & Johnson Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.8.5 Johnson & Johnson Recent Development
    • 12.9 GSK
      • 12.9.1 GSK Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.9.5 GSK Recent Development
    • 12.10 Sanofi
      • 12.10.1 Sanofi Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction
      • 12.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2014-2019)
      • 12.10.5 Sanofi Recent Development
    • 12.11 Boehringer Ingelheim
    • 12.12 Zhejiang Jiuzhou Pharmaceutical Co

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.
      In 2018, the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) development in United States, Europe and China.

      The key players covered in this study
      Roche (including Genentech)
      Amgen
      B-MS
      Merck
      Pfizer
      Novartis
      Eli Lilly and Company
      Johnson & Johnson
      GSK
      Sanofi
      Boehringer Ingelheim
      Zhejiang Jiuzhou Pharmaceutical Co

      Market segment by Type, the product can be split into
      Aspirin
      Ibuprofen
      Naproxen
      Celecoxib
      Others

      Market segment by Application, split into
      Drug Store
      Hospital Pharmacies
      Online

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) status, future forecast, growth opportunity, key market and key players.
      To present the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now